Travelers often ask for a single “best” antibiotic for traveler’s diarrhea, but that is not how clinicians usually think about the decision. The better question is which option fits the likely illness pattern, the trip context, and the traveler’s own medication profile.
This guide explains how clinicians think about azithromycin versus rifaximin for traveler’s diarrhea, why the choice is not interchangeable in every situation, and when it makes sense to review your options before a trip. If you want personalized guidance, you can start a Runway Health consultation online.
Why these two medications are not used the same way
The CDC Yellow Book guidance on traveler’s diarrhea makes an important distinction: azithromycin is preferred for dysentery or febrile diarrhea, while rifaximin is reserved for moderate, noninvasive diarrhea and should not be used when invasive pathogens are suspected. That difference shapes the decision before anything else.
How clinicians think about azithromycin
Where azithromycin has an advantage
Azithromycin is often the more flexible standby option because it can be used when diarrhea is severe, involves fever, or looks invasive. CDC also notes that it is first-line empiric treatment in areas where fluoroquinolone-resistant bacteria are a concern.
Why it is not automatically the default for everyone
Even when azithromycin is effective, clinicians still weigh side effects, medication interactions, traveler history, and whether the traveler is likely to use antibiotics appropriately.
How clinicians think about rifaximin
Where rifaximin fits best
Rifaximin can be useful for some travelers with moderate, noninvasive diarrhea, especially when azithromycin is a poor fit or when a traveler wants an option targeted to noninvasive bacterial diarrhea.
Its key limitation
CDC states that rifaximin should not be used if invasive pathogens such as Campylobacter, Salmonella, or Shigella are suspected. In practice, that means it can be less versatile as a single standby option because travelers may not always be able to tell whether the illness is invasive.
Start Your Travel Consultation ➜
Questions that influence the choice
- Where are you traveling? Regional resistance patterns matter.
- How severe would illness be for your trip plans? Some travelers need a more flexible standby option.
- Do you have medication interactions or tolerability issues?
- Would you know when to avoid an antibiotic and focus on hydration and symptom control instead?
- Do you need a plan that also includes loperamide or oral rehydration?
What usually belongs in the plan besides the antibiotic
For many travelers, the full plan matters more than the name of the antibiotic alone. That often includes oral rehydration, loperamide when appropriate, and clear instructions on when to seek medical care. For more background, see our guide to traveler’s diarrhea antibiotics.
The bottom line
Azithromycin and rifaximin are not interchangeable backup prescriptions. Azithromycin is generally the more flexible option when invasive diarrhea is on the table, while rifaximin fits a narrower noninvasive use case. The right choice depends on itinerary, health history, and clinician judgment.
Prescribing decisions are always clinician discretion and should be individualized to the traveler.
Review Your Travel Medications Online ➜
